Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1145633010 | 11456330 | 10 | F | 20150911 | 20160914 | 20150903 | 20160920 | EXP | US-ACTELION-A-NJ2015-123537 | ACTELION | 82.00 | YR | E | F | Y | 0.00000 | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1145633010 | 11456330 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6-9X DAILY | MA026ST;MA029A9,MA02DL0 | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
| 1145633010 | 11456330 | 2 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 5-9X DAILY | MA026ST;MA029A9 | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
| 1145633010 | 11456330 | 3 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK UNK, QID | MA026ST;MA029A9 | 21779 | INHALATION VAPOUR, SOLUTION | QID | |||||||
| 1145633010 | 11456330 | 4 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK UNK, QID | MA029A9 | 21779 | INHALATION VAPOUR, SOLUTION | QID | |||||||
| 1145633010 | 11456330 | 5 | C | ADCIRCA | TADALAFIL | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 1145633010 | 11456330 | 6 | C | LETAIRIS | AMBRISENTAN | 1 | U | 0 | |||||||||||
| 1145633010 | 11456330 | 7 | C | SILDENAFIL. | SILDENAFIL | 1 | U | 0 | |||||||||||
| 1145633010 | 11456330 | 8 | C | WARFARIN | WARFARIN | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 1145633010 | 11456330 | 9 | C | TORSEMIDE. | TORSEMIDE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | BID | ||||||
| 1145633010 | 11456330 | 10 | C | PROLIA | DENOSUMAB | 1 | 60 MG/ML SOLUTION, 1 SHOT EVERY 6 MONTHS | U | 0 | ||||||||||
| 1145633010 | 11456330 | 11 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 1145633010 | 11456330 | 12 | C | DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 120 MG, QD | U | 0 | 120 | MG | QD | ||||||
| 1145633010 | 11456330 | 13 | C | FISH OIL | FISH OIL | 1 | Oral | 1 CAPSULE, QD | U | 0 | QD | ||||||||
| 1145633010 | 11456330 | 14 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 1145633010 | 11456330 | 15 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 1145633010 | 11456330 | 16 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 137 MCG, QD | U | 0 | 137 | UG | QD | ||||||
| 1145633010 | 11456330 | 17 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 1145633010 | 11456330 | 18 | C | FLECAINIDE | FLECAINIDE | 1 | U | 0 | |||||||||||
| 1145633010 | 11456330 | 19 | C | LASIX | FUROSEMIDE | 1 | 80 MG, QD | 0 | 80 | MG | QD | ||||||||
| 1145633010 | 11456330 | 20 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 10 MG, QD | U | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1145633010 | 11456330 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1145633010 | 11456330 | HO |
| 1145633010 | 11456330 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1145633010 | 11456330 | Ankle fracture | |
| 1145633010 | 11456330 | Aortic arteriosclerosis | |
| 1145633010 | 11456330 | Bronchitis | |
| 1145633010 | 11456330 | Cardiac failure congestive | |
| 1145633010 | 11456330 | Condition aggravated | |
| 1145633010 | 11456330 | Device issue | |
| 1145633010 | 11456330 | Diarrhoea | |
| 1145633010 | 11456330 | Dizziness | |
| 1145633010 | 11456330 | Dyspnoea | |
| 1145633010 | 11456330 | Exercise tolerance decreased | |
| 1145633010 | 11456330 | Fall | |
| 1145633010 | 11456330 | Heart rate increased | |
| 1145633010 | 11456330 | Hip fracture | |
| 1145633010 | 11456330 | Left ventricular end-diastolic pressure increased | |
| 1145633010 | 11456330 | Mitral valve stenosis | |
| 1145633010 | 11456330 | Oedema | |
| 1145633010 | 11456330 | Open reduction of fracture | |
| 1145633010 | 11456330 | Orthopnoea | |
| 1145633010 | 11456330 | Pelvic fracture | |
| 1145633010 | 11456330 | Pulmonary hypertension | |
| 1145633010 | 11456330 | Rash | |
| 1145633010 | 11456330 | Right ventricular enlargement | |
| 1145633010 | 11456330 | Right ventricular systolic pressure decreased | |
| 1145633010 | 11456330 | Sleep apnoea syndrome | |
| 1145633010 | 11456330 | Somnolence | |
| 1145633010 | 11456330 | Tricuspid valve incompetence | |
| 1145633010 | 11456330 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1145633010 | 11456330 | 1 | 20090616 | 0 |